Showing 1 - 10 results of 10 for search 'Daniel C. Malone', query time: 0.07s Refine Results
  1. 1
    Cost-Effectiveness Analysis of a Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder

    Cost-Effectiveness Analysis of a Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder by Fulton F. Velez, Daniel C. Malone

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Interpretable Machine Learning Prediction of Drug-Induced QT Prolongation: Electronic Health Record Analysis

    Interpretable Machine Learning Prediction of Drug-Induced QT Prolongation: Electronic Health Record Analysis by Steven T Simon, Katy E Trinkley, Daniel C Malone, Michael Aaron Rosenberg

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    A systematic review of real-world healthcare resource use and costs of Clostridioides difficile infections

    A systematic review of real-world healthcare resource use and costs of Clostridioides difficile infections by Daniel C. Malone, Edward P. Armstrong, Dan Gratie, Sissi V. Pham, Alpesh Amin

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Societal perspectives on disease and treatment attributes characterizing rare diseases: a qualitative study from the United States

    Societal perspectives on disease and treatment attributes characterizing rare diseases: a qualitative study from the United States by Shelagh M. Szabo, Ivana F. Audhya, David Feeny, Peter Neumann, Daniel C. Malone, Katherine L. Gooch

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Short-term efficacy of non-pharmacological interventions for global population with elevated blood pressure: A network meta-analysis

    Short-term efficacy of non-pharmacological interventions for global population with elevated blood pressure: A network meta-analysis by Taihang Shao, Leyi Liang, Chengchao Zhou, Yaqian Tang, Wenqing Gao, Yusi Tu, Yue Yin, Daniel C. Malone, Wenxi Tang, Wenxi Tang

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Cost-effectiveness analysis of using onasemnogene abeparvocec (AVXS-101) in spinal muscular atrophy type 1 patients

    Cost-effectiveness analysis of using onasemnogene abeparvocec (AVXS-101) in spinal muscular atrophy type 1 patients by Daniel C. Malone, Rebecca Dean, Ramesh Arjunji, Ivar Jensen, Phil Cyr, Beckley Miller, Benit Maru, Douglas M. Sproule, Douglas E. Feltner, Omar Dabbous

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Assessing the value of delandistrogene moxeparvovec (SRP-9001) gene therapy in patients with Duchenne muscular dystrophy in the United States

    Assessing the value of delandistrogene moxeparvovec (SRP-9001) gene therapy in patients with Duchenne muscular dystrophy in the United States by Alexa C. Klimchak, Lauren E. Sedita, Louise R. Rodino-Klapac, Jerry R. Mendell, Craig M. McDonald, Katherine L. Gooch, Daniel C. Malone

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Estimating health state utilities in Duchenne muscular dystrophy using the health utilities index and EQ-5D-5L

    Estimating health state utilities in Duchenne muscular dystrophy using the health utilities index and EQ-5D-5L by Ivana F. Audhya, Shelagh M. Szabo, Andrea Bever, Fiona O'Sullivan, Daniel C. Malone, David Feeny, Peter Neumann, Susan T. Iannaccone, P. Jayasinghe, Katherine L. Gooch

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and Effectiveness Review (ICER)

    An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and... by Rebecca Dean, Ivar Jensen, Phil Cyr, Beckley Miller, Benit Maru, Douglas M. Sproule, Douglas E. Feltner, Thomas Wiesner, Daniel C. Malone, Matthias Bischof, Walter Toro, Omar Dabbous

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    A Minimal Information Model for Potential Drug-Drug Interactions

    A Minimal Information Model for Potential Drug-Drug Interactions by Harry Hochheiser, Harry Hochheiser, Xia Jing, Elizabeth A. Garcia, Serkan Ayvaz, Ratnesh Sahay, Michel Dumontier, Juan M. Banda, Oya Beyan, Mathias Brochhausen, Evan Draper, Sam Habiel, Oktie Hassanzadeh, Maria Herrero-Zazo, Brian Hocum, John Horn, Brian LeBaron, Daniel C. Malone, Øystein Nytrø, Thomas Reese, Katrina Romagnoli, Jodi Schneider, Louisa (Yu), Richard D. Boyce, Richard D. Boyce

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: